nuBeam BNCT Suite
Head and Neck Cancer, other solid tumors
Key Facts
About Neutron Therapeutics
Neutron Therapeutics is a private, clinical-stage company pioneering the development and commercialization of hospital-based Boron Neutron Capture Therapy (BNCT) systems. The company has established itself as a leader in the field, with multiple systems shipped and installed internationally, including the first accelerator-based BNCT platform in Europe at Helsinki University Hospital. While its lead system, the nuBeam BNCT Suite, remains investigational and not yet approved by the FDA or PMDA, the company has progressed to treating head and neck cancer patients in clinical settings abroad. Neutron Therapeutics operates in a high-potential but nascent radiotherapy niche, facing significant regulatory and commercial adoption hurdles.
View full company profile